Syphilis has shot up sharply in recent years as public health resources flowed elsewhere, dashing the optimism of the early 2000s that the disease might be stamped out,
A big GHN welcome to Kaila Dodd, a new writing intern with the Johns Hopkins Bloomberg School of Public Health. We’re delighted to have a chance to feature her work in GHN, too! Kaila recently graduated from Baltimore’s Morgan State University, where she majored in…
The American opioid crisis may be sidelined by COVID-19, but its death toll is higher than ever.
A digital exhibition examining the intersection of immigration and public health over 130 years has uplifting moments—like home visits immigrants by New York nurses to curb infant mortality and the spread of disease.
Birth workers of color believe that growing their ranks could help improve outcomes for Black mothers and babies—but it’s also an access issue.
While the CDC and FDA review data today on reports that 6 women experienced very rare but serious blood clots in the brain after receiving the Johnson & Johnson jab, public health experts offered advice–and reassurance that the risk is low–-to the ~7million who already…
In central and South America, progress against tuberculosis is reversing for reasons not fully understood–-but it’s clear the scourge is increasingly concentrated in the region’s prisons. Since 2000, TB has swelled in the population by 206%.
One possibility: US regulators could follow the lead of Europe, which limited the AstraZeneca vaccine to certain age groups; or it may add cautionary clauses,
The CDC and FDA recommended a temporary pause on the use of Johnson & Johnson’s COVID-19 vaccine in the US out of “an abundance of caution” over 6 cases of a rare but severe type of blood clot among recipients,
Islamic scholars have urged Muslims not to delay COVID-19 vaccines on account of Ramadan–-but the holiday could still drive up hesitation.